NL7105591A - Topical antiphlogistic compsns - contng 3, 20-diketo-9 alpha, 11 beta-dichloro - 16 alpha, 17 alpha-dimethyl-21-hydroxy pregna-1,4- - Google Patents

Topical antiphlogistic compsns - contng 3, 20-diketo-9 alpha, 11 beta-dichloro - 16 alpha, 17 alpha-dimethyl-21-hydroxy pregna-1,4-

Info

Publication number
NL7105591A
NL7105591A NL7105591A NL7105591A NL7105591A NL 7105591 A NL7105591 A NL 7105591A NL 7105591 A NL7105591 A NL 7105591A NL 7105591 A NL7105591 A NL 7105591A NL 7105591 A NL7105591 A NL 7105591A
Authority
NL
Netherlands
Prior art keywords
alpha
compsns
diketo
dichloro
beta
Prior art date
Application number
NL7105591A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to NL7105591A priority Critical patent/NL7105591A/en
Publication of NL7105591A publication Critical patent/NL7105591A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Abstract

Compsns. contg. 0.1-1.0% 3,20-diketo-9 alpha, 11 beta-dichloro-16 alpha, 17 alpha-dimethyl-21-hydroxypregna-1,4-diene and its 21-esters are powerful topical anti-phlogistics with no. appreciable systemic activity. The esters (other than the acetate) are novel.
NL7105591A 1971-04-24 1971-04-24 Topical antiphlogistic compsns - contng 3, 20-diketo-9 alpha, 11 beta-dichloro - 16 alpha, 17 alpha-dimethyl-21-hydroxy pregna-1,4- NL7105591A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NL7105591A NL7105591A (en) 1971-04-24 1971-04-24 Topical antiphlogistic compsns - contng 3, 20-diketo-9 alpha, 11 beta-dichloro - 16 alpha, 17 alpha-dimethyl-21-hydroxy pregna-1,4-

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7105591A NL7105591A (en) 1971-04-24 1971-04-24 Topical antiphlogistic compsns - contng 3, 20-diketo-9 alpha, 11 beta-dichloro - 16 alpha, 17 alpha-dimethyl-21-hydroxy pregna-1,4-

Publications (1)

Publication Number Publication Date
NL7105591A true NL7105591A (en) 1972-10-26

Family

ID=19813009

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7105591A NL7105591A (en) 1971-04-24 1971-04-24 Topical antiphlogistic compsns - contng 3, 20-diketo-9 alpha, 11 beta-dichloro - 16 alpha, 17 alpha-dimethyl-21-hydroxy pregna-1,4-

Country Status (1)

Country Link
NL (1) NL7105591A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0231958A1 (en) * 1986-01-15 1987-08-12 Akzo N.V. Novel pregnane derivatives, processes for their preparaton and pharmaceutical compositions containing same
US11213587B2 (en) 2010-11-22 2022-01-04 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
US11648256B2 (en) 2015-06-18 2023-05-16 Bausch Health Ireland Limited Topical compositions and methods for treating psoriasis
US11839656B2 (en) 2010-11-22 2023-12-12 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0231958A1 (en) * 1986-01-15 1987-08-12 Akzo N.V. Novel pregnane derivatives, processes for their preparaton and pharmaceutical compositions containing same
US11213587B2 (en) 2010-11-22 2022-01-04 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
US11839656B2 (en) 2010-11-22 2023-12-12 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
US11957753B2 (en) 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
US11648256B2 (en) 2015-06-18 2023-05-16 Bausch Health Ireland Limited Topical compositions and methods for treating psoriasis
US11679115B2 (en) 2015-06-18 2023-06-20 Bausch Health Ireland Limited Topical compositions and methods for treating psoriasis
US11679116B2 (en) 2015-06-18 2023-06-20 Bausch Health Ireland Limited Topical compositions and methods for treating psoriasis

Similar Documents

Publication Publication Date Title
NL7105591A (en) Topical antiphlogistic compsns - contng 3, 20-diketo-9 alpha, 11 beta-dichloro - 16 alpha, 17 alpha-dimethyl-21-hydroxy pregna-1,4-
CA969175A (en) 6.alpha.,9.alpha.-DIFLUOROSTEROIDS OF THE PREGNANE SERIES AND PROCESSES FOR THEIR MANUFACTURE
CA683033A (en) OPTICALLY-ACTIVE .alpha.-ALKYL-SUBSTITUTED PHENOXYACETIC ACIDS AND PROCESSES FOR PRODUCING THE SAME
CA689986A (en) 11.alpha.,17.alpha.,21-TRIHYDROXY-4-PREGNENE-3,20-DIONE ESTERS
CA700471A (en) 9,11-DICHLORO-.DELTA.1,4-PREGNADIENE-16.alpha.,17.alpha.,-21-TRIOL-3,20-DIONES 16,17-ACETONIDES AND THEIR 21-ESTERS
CA831977A (en) 17-(UNSATURATED HYDROCARBON-SUBSTITUTED) 11,13.beta.-DIALKYLGON-4-ENE-3,17.beta.-DIOLS AND ESTERS THEREOF
CA730683A (en) ESTERS OF 17.alpha.-ETHYNYLESTR-5(10)-ENE-3.beta.,17.beta.-DIOL AND PROCESS
CA737450A (en) 16.alpha.-ALKYL-17.alpha.,21-DIHYDROXY-4-PREGNENE-3,20-DIONE 21-ACYLATE
CA883818A (en) 4-CHLORO-1,2.alpha.-METHYLENE-.DELTA.4,6-PREGNADIEN-17.alpha.-O1-3,20-DIONE AND ITS 17-ESTERS
CA700231A (en) 4-HYDROXY-17.alpha.-METHYL-19-NOR-TESTOSTERONE, 4,11.beta.-DIHYDROXY-17.alpha.-METHYL-TESTOSTERONE AND ESTERS THEREOF
CA740874A (en) PROCESS FOR THE PRODUCTION OF OPTIONALLY 17-ALKYLATED AND 6-METHYLATED 5.alpha.-ANDROST-1-ENE-3.beta.,17.beta.-DIOL AND ESTERS THEREOF
CA845005A (en) Gas diffuser nozzle
CA848427A (en) 17.alpha.-ARALIPHATYLESTRA-1,3,5(10)-TRIENE-3-11.beta.,17.beta.-TRIOLS AND ESTERS THEREOF
CA638323A (en) 9.alpha.-HALO-ALLOPREGNANES AND ESTERS THEREOF
CA733958A (en) 2.alpha.,16.alpha.-DIMETHYL-11,17-DIHYDROXY-21-DESOXY-4-PREGNENE-3,20-DIONES, THE CORRESPONDING 11-KETO ANALOGUES THEREOF, AND THE 9.alpha.-HALO DERIVATIVES OF THE FOREGOING
CA855688A (en) 6.alpha.,16.beta.-DIMETHYL STEROIDS OF THE 4-PREGNENE AND .DELTA.1,4 PREGNADIENE SERIES
CA670139A (en) 6.alpha.-METHYL-11-OXYGENATED-17,21-EPOXY-4-PREGNENE-3,20-DIONE AND ITS .DELTA.1,4-DERIVATIVE
CA769710A (en) 6.alpha.-CHLORO-.DELTA.1,4-PREGNADIENE-17.alpha.-21-DIOL-3,11,20-TRIONE AND ITS ESTERS
CA646564A (en) 11.alpha.,17.alpha.,21-TRIHYDROXY-4-PREGNENE-3,20-DIONE
CA610350A (en) Esters of 14,17,21-trihydroxy-4-pregnene-3,20-dione
CA868338A (en) 6.alpha.,16.beta.-DIMETHYL STEROIDS OF THE 4-PREGNENE AND .DELTA.1-4-PREGNADIENE SERIES
CA730698A (en) 11,18,21-trioxygenated 20-oxo-pregnanes and esters thereof and processfor their manufacture
CA641618A (en) Convertible diffuser
CA683162A (en) 9.alpha.-FLUORO-1,4-PREGNADIENES-11.beta.,16.alpha.,17.alpha.,21-TETROL-3,20-DIONES AND ITS 16,21-LOWER ALKANOATES
CA646690A (en) SYNTHESIS OF .DELTA.1,4-PREGNADIENE-17.alpha.,21-DIOL-3,20-DIONE